Medical Professional Mutual Insurance v. Breon Laboratories, Inc.

[NOT FOR PUBLICATION--NOT TO BE CITED AS PRECEDENT] UNITED STATES COURT OF APPEALS FOR THE FIRST CIRCUIT No. 97-1654 THE MEDICAL PROFESSIONAL MUTUAL INSURANCE COMPANY, ET AL., Plaintiffs, Appellants, v. BREON LABORATORIES, INC. AND STERLING WINTHROP, INC., Defendants, Appellees. No. 97-1837 THE MEDICAL PROFESSIONAL MUTUAL INSURANCE COMPANY, ET AL., Plaintiffs, Appellants, v. BREON LABORATORIES, INC. AND STERLING WINTHROP, INC., Defendants, Appellees. APPEALS FROM THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MASSACHUSETTS [Hon. William G. Young, U.S. District Judge] Before Stahl, Circuit Judge, Cyr, Senior Circuit Judge, and Shadur, Senior District Judge. Edward D. McCarthy, with whom Ann L. Simoneau, McCarthy, Bouley & Barry, Michael E. Mone and Esdaile, Barrett & Esdaile were on brief for appellants. Peter B. Ellis, with whom Michael P. Boudett and Foley Hoag & Eliot LLP were on brief for appellees. March 31, 1999 Per curiam. In March 1994, Dr. Lawrence Simons and his insurer ("appellants") settled the medical malpractice action brought by a former patient who had been seriously injured by an anesthetic drug improperly administered by Simons in 1981. Within a year of the settlement, appellants brought suit in federal district court against the drug manufacturer, Breon Laboratories, Inc. ("Breon"), seeking contribution, as well as damages for Breon's negligence, breach of warranty, infliction of emotional distress, and unfair trade practices. Finding all claims barred by the various statutes of limitations, the district court granted summary judgment for Breon. As to appellants' contribution claim, we concluded that the limitations provisions of the Massachusetts Contribution Among Joint Tortfeasors Act, Mass. Gen. Laws Ann. ch. 231B, 3(c),(d), were susceptible to differing interpretations, and therefore certified the question to the Supreme Judicial Court of Massachusetts ("SJC"). See Medical Professional Mut. Ins. Co. v. Breon Labs., Inc., 141 F.3d 372 (1st Cir. 1998). The SJC having responded in appellants' favor, see Medical Professional Mut. Ins. Co. v. Breon Labs., Inc., 705 N.E.2d 260 (Mass. 1999), we now vacate the district court's dismissal of appellants' contribution claim and remand to the district court for further proceedings. As to appellants' other tort and contract claims, however, we affirm the district court dismissal. The respective limitations periods ran from the time appellants were first on notice that they had suffered some appreciable harm at Breon's hands, whether or not they appreciated the full extent of the harm. See, e.g., White v. Peabody Constr. Co., 434 N.E.2d 1015, 1020 (Mass. 1982). Dr. Simons admits that he first suffered emotional damages in 1981, upon observing his patient's violent reaction to the drug. In 1996, moreover, Simons unambiguously attested that he suffered no economic losses or out-of-pocket damages. A year later, Simons attested (without supporting documentation) that he personally paid to retain an attorney in November 1993 to handle any liability claims in excess of his insurance coverage. Such belated, thinly-veiled attempts to skirt a statute-of-limitations bar are futile. See Colantuoni v. Alfred Calcagni & Sons, Inc., 44 F.3d 1, 4-5 (1st Cir. 1994) ("When an interested witness has given clear answers to unambiguous questions, he cannot create a conflict and resist summary judgment with an affidavit that is clearly contradictory, but does not give a satisfactory explanation of why the testimony is changed."). Similarly, Simons' insurer first expended funds in 1985 to defend Simons against the malpractice suit. SeeMassachusetts Elec. Co. v. Fletcher, Tilton & Whipple, P.C., 475 N.E.2d 390, 392 (Mass. 1985). Thus, its contention that it did not suffer appreciable harm until the March 1994 settlement is disingenuous. The judgment dismissing appellants' contribution claim is vacated and remanded for further proceedings. In all other respects, the judgment is affirmed. Costs to appellants.